Semaglutide, a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, works by activating brain receptors that regulate hunger and slowing gastric emptying
Even tiny particles can indicate contamination or degradation
Almandoz JP, Wadden TA, Tewksbury C, Apovian CM, Fitch A, Ard JD, et al
As a result of taking the medication, some people may experience nausea, constipation, or stomachaches
To book an appointment to begin microdosing, use the promo code MICRODOSE to get your first appointment and first five weeks of dosing/ medication for $299
These symptoms can lead to reduced fluid intake and increased fluid losses, resulting in dehydration